Rep. Thomas H. Kean, Jr. Purchases Shares of Danaher Corporation (NYSE:DHR)

Key Points

• Representative Thomas H. Kean, Jr. purchased shares of Danaher Corporation (NYSE:DHR), investing between $1,001 and $15,000 in early September.
• Danaher recently announced a quarterly dividend of $0.32 per share, reflecting an annualized yield of 0.6%, with the dividend payout scheduled for October 31.
• Wall Street analysts have given Danaher a consensus rating of "Moderate Buy" with a target price of approximately $244.60, reflecting positive sentiments toward the company's growth potential.

Representative Thomas H. Kean, Jr. (R-New Jersey) recently bought shares of Danaher Corporation NYSE: DHR. In a filing disclosed on October 14th, the Representative disclosed that they had bought between $1,001 and $15,000 in Danaher stock on September 3rd. The trade occurred in the Representative's "KEAN FAMILY PARTNERSHIP" account.

Representative Thomas H. Kean, Jr. also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Intercontinental Exchange NYSE: ICE on 9/25/2025.
• Sold $1,001 - $15,000 in shares of Oracle NYSE: ORCL on 9/15/2025.
• Sold $15,001 - $50,000 in shares of Markel Group NYSE: MKL on 9/12/2025.
• Sold $15,001 - $50,000 in shares of Stryker NYSE: SYK on 9/12/2025.
• Sold $15,001 - $50,000 in shares of Oracle NYSE: ORCL on 9/12/2025.
• Sold $15,001 - $50,000 in shares of Franklin Resources NYSE: BEN on 9/3/2025.
• Purchased $1,001 - $15,000 in shares of Franco-Nevada NYSE: FNV on 9/3/2025.
• Sold $1,001 - $15,000 in shares of Stryker NYSE: SYK on 8/25/2025.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 8/25/2025.
• Purchased $1,001 - $15,000 in shares of Canadian Pacific Kansas City NYSE: CP on 8/22/2025.

Danaher Trading Up 2.3%

Shares of DHR stock opened at $210.86 on Friday. The company has a market cap of $150.99 billion, a price-to-earnings ratio of 44.86, a PEG ratio of 2.94 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm has a fifty day moving average price of $201.43 and a 200-day moving average price of $197.23. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.41.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.Danaher's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher's payout ratio is presently 27.23%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on DHR. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Barclays restated an "overweight" rating and set a $225.00 target price (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Bank of America lowered their price objective on Danaher from $230.00 to $220.00 and set a "buy" rating on the stock in a research report on Monday, September 22nd. Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective for the company in a research note on Friday, July 11th. Finally, Robert W. Baird lifted their target price on Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a research note on Friday, July 18th. Seventeen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $244.60.

Institutional Trading of Danaher

Large investors have recently added to or reduced their stakes in the company. MGO One Seven LLC increased its holdings in shares of Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after buying an additional 20,813 shares during the last quarter. Chicago Capital LLC increased its stake in Danaher by 11.6% during the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate's stock worth $2,634,000 after acquiring an additional 1,391 shares during the last quarter. UniSuper Management Pty Ltd increased its position in shares of Danaher by 1.6% during the 1st quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate's stock valued at $34,954,000 after purchasing an additional 2,667 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new position in shares of Danaher during the 1st quarter valued at approximately $539,000. Finally, Horizon Financial Services LLC increased its position in shares of Danaher by 20,400.0% during the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock valued at $1,681,000 after purchasing an additional 8,160 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the business's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 11.10% of the stock is owned by company insiders.

About Representative Kean

Thomas Kean Jr. (Republican Party) is a member of the U.S. House, representing New Jersey's 7th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Kean (Republican Party) is running for re-election to the U.S. House to represent New Jersey's 7th Congressional District. He declared candidacy for the 2026 election. Thomas Kean Jr. lives in Westfield, New Jersey. Kean earned a master’s degree from the Tufts University Fletcher School of Law and Diplomacy. His career experience includes working with the Environmental Protection Agency during the George H.W. Bush administration and as an advisor to former U.S. Representative Bob Franks, a firefighter, and an emergency medical technician. Kean has served as the vice president of a fire department.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.